ArticleTargeted oncology2018

Effect of Changes in Skeletal Muscle Mass on Oncological Outcomes During First-Line Sunitinib Therapy for Metastatic Renal Cell Carcinoma.

Hiroki Ishihara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.